MA39077A1 - Combinaison de glycosaminoglycanes et de cyclodextrines - Google Patents
Combinaison de glycosaminoglycanes et de cyclodextrinesInfo
- Publication number
- MA39077A1 MA39077A1 MA39077A MA39077A MA39077A1 MA 39077 A1 MA39077 A1 MA 39077A1 MA 39077 A MA39077 A MA 39077A MA 39077 A MA39077 A MA 39077A MA 39077 A1 MA39077 A1 MA 39077A1
- Authority
- MA
- Morocco
- Prior art keywords
- combination
- cyclodextrins
- glycosaminoglycans
- treatment
- articular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
L'invention concerne une combinaison injectable de deux parmi les glycosaminoglycanes spécifiques, l'acide hyaluronique et le sulfate de chondroïtine, avec des cyclodextrines et l'utilisation de la combinaison pour le traitement de maladies liées au squelette, en particulier dans le traitement intra-articulaire, ainsi que dans le traitement intradermique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT002116A ITMI20132116A1 (it) | 2013-12-18 | 2013-12-18 | Associazione di glicosamminoglicani e ciclodestrine |
PCT/IB2014/002774 WO2015092516A1 (fr) | 2013-12-18 | 2014-12-15 | Combinaison de glycosaminoglycanes et de cyclodextrines |
Publications (1)
Publication Number | Publication Date |
---|---|
MA39077A1 true MA39077A1 (fr) | 2017-11-30 |
Family
ID=50115999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA39077A MA39077A1 (fr) | 2013-12-18 | 2014-12-15 | Combinaison de glycosaminoglycanes et de cyclodextrines |
Country Status (13)
Country | Link |
---|---|
US (1) | US9974803B2 (fr) |
EP (1) | EP3082869B1 (fr) |
CN (1) | CN105899233B (fr) |
BR (1) | BR112016013834B1 (fr) |
CA (1) | CA2932987C (fr) |
EA (1) | EA032372B1 (fr) |
ES (1) | ES2707971T3 (fr) |
IT (1) | ITMI20132116A1 (fr) |
MA (1) | MA39077A1 (fr) |
PT (1) | PT3082869T (fr) |
TN (1) | TN2016000206A1 (fr) |
TR (1) | TR201819270T4 (fr) |
WO (1) | WO2015092516A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUB20153110A1 (it) * | 2015-08-13 | 2017-02-13 | Alfakjn S R L | Composizione liquida iniettabile per uso nella terapia infiltrativa intra-articolare |
IT201600075246A1 (it) | 2016-07-19 | 2018-01-19 | Jointherapeutics S R L | Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi. |
IT201800010415A1 (it) * | 2018-11-19 | 2020-05-19 | Innate S R L | Composizione iniettabile comprendente acido ialuronico e trealosio e uso della detta composizione. |
KR20230019195A (ko) * | 2020-06-02 | 2023-02-07 | 내셔널 유니버시티 오브 싱가포르 | 조성물들, 요법에서 그것들의 용도들 및 이의 방법들 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK282717B6 (sk) * | 2000-03-10 | 2002-11-06 | �Stav Experiment�Lnej Farmakol�Gie Sav | Spôsob prípravy ultravysokomolekulových hyalurónanov |
FR2811572B1 (fr) | 2000-07-17 | 2003-04-18 | Adir | Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose |
MXPA01011542A (es) * | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel. |
AU2003279835B2 (en) * | 2002-10-07 | 2009-09-10 | Zymogenetics, Inc. | Methods of administering FGF18 |
US8455458B2 (en) * | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
CN1451369A (zh) * | 2003-03-13 | 2003-10-29 | 吉林大学 | 环糊精衍生物在化妆品中的应用 |
EP1967186B1 (fr) * | 2005-12-27 | 2015-03-11 | Lion Corporation | Composition pour lentilles de contact souples et procede permettant la suppression de l' adsorption |
CN100594029C (zh) * | 2006-07-24 | 2010-03-17 | 凌沛学 | 一种关节腔内注射用药物组合物 |
US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
CN101259139A (zh) * | 2008-03-13 | 2008-09-10 | 北京阜康仁生物制药科技有限公司 | 一种用于消炎镇痛的药用组合物 |
KR20110067130A (ko) * | 2008-09-22 | 2011-06-21 | 아카리오스 비.브이. | 약제로서 유용한 카르복시에틸화 사이클로덱스트린 폴리설페이트 |
ITPD20120098A1 (it) * | 2012-03-30 | 2013-10-01 | Fidia Farmaceutici | "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico" |
CH705713B1 (de) * | 2012-09-21 | 2013-05-15 | Labo Cosprophar Ag | Dermokosmetische Zusammensetzung zur topischen Anwendung. |
CN103301118A (zh) * | 2013-06-27 | 2013-09-18 | 海南卫康制药(潜山)有限公司 | 注射用精氨酸布洛芬组合物 |
-
2013
- 2013-12-18 IT IT002116A patent/ITMI20132116A1/it unknown
-
2014
- 2014-12-15 TR TR2018/19270T patent/TR201819270T4/tr unknown
- 2014-12-15 ES ES14830561T patent/ES2707971T3/es active Active
- 2014-12-15 TN TN2016000206A patent/TN2016000206A1/en unknown
- 2014-12-15 US US15/105,595 patent/US9974803B2/en active Active
- 2014-12-15 MA MA39077A patent/MA39077A1/fr unknown
- 2014-12-15 WO PCT/IB2014/002774 patent/WO2015092516A1/fr active Application Filing
- 2014-12-15 CN CN201480069024.0A patent/CN105899233B/zh active Active
- 2014-12-15 BR BR112016013834-1A patent/BR112016013834B1/pt active IP Right Grant
- 2014-12-15 CA CA2932987A patent/CA2932987C/fr active Active
- 2014-12-15 PT PT14830561T patent/PT3082869T/pt unknown
- 2014-12-15 EP EP14830561.8A patent/EP3082869B1/fr active Active
- 2014-12-15 EA EA201691246A patent/EA032372B1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EP3082869A1 (fr) | 2016-10-26 |
BR112016013834B1 (pt) | 2022-11-22 |
EP3082869B1 (fr) | 2018-10-31 |
CN105899233B (zh) | 2020-01-17 |
CA2932987C (fr) | 2021-10-12 |
PT3082869T (pt) | 2019-02-06 |
ES2707971T3 (es) | 2019-04-08 |
CN105899233A (zh) | 2016-08-24 |
BR112016013834A2 (fr) | 2017-08-08 |
EA032372B1 (ru) | 2019-05-31 |
CA2932987A1 (fr) | 2015-06-25 |
EA201691246A1 (ru) | 2016-10-31 |
TN2016000206A1 (en) | 2017-10-06 |
WO2015092516A1 (fr) | 2015-06-25 |
ITMI20132116A1 (it) | 2015-06-19 |
TR201819270T4 (tr) | 2019-01-21 |
US20170035799A1 (en) | 2017-02-09 |
US9974803B2 (en) | 2018-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018075250A2 (pt) | composição na forma de uma solução aquosa injetável, cujo ph é de 6,0 a 8,0 | |
MX355080B (es) | Mejora de la apariencia de la piel con aumento en la intensidad cromatica de la piel. | |
IL235966B (en) | Aqueous compositions with a ph level of 6 containing anti-Baffr antibody without fucosylation for use in the treatment of autoimmune diseases | |
BR112014017650A2 (pt) | composições e uso de ésteres de forbol | |
MA35365B1 (fr) | Pyrimidines annelées substituées et leur utilisation | |
BR112016013109A2 (pt) | anticorpos de anti-siglec-8 e métodos de seu uso | |
MA39077A1 (fr) | Combinaison de glycosaminoglycanes et de cyclodextrines | |
MY161209A (en) | Silicone hydrogel contact lenses and related compositions and methods | |
PE20210949A1 (es) | Anticuerpos anti-fgfr2iiib afucosilados | |
BR112015018438A2 (pt) | anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento | |
MA38273A1 (fr) | Thérapie de combinaison avec des anticorps anti-her3 | |
BR112015012322A2 (pt) | líquido detergente aquoso espessado e processo de fabricação de composição detergente | |
FR3028753B1 (fr) | Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application | |
FR3020570B1 (fr) | Association d'un acide hyaluronique et d'un polysaccharide sulfate | |
BR112015001668A2 (pt) | componente híbrido e processo de produção | |
BR112015003957A2 (pt) | alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria | |
MA38369B1 (fr) | Peptides et compositions pour le traitement d'une lesion de l'articulation | |
IN2014DN06700A (fr) | ||
EA201691828A1 (ru) | Прозрачное экструдированное туалетное мыло | |
MX2013011971A (es) | Tratamiento de enfermedades con nanofibras de poli-n-acetil-glucosamina. | |
FR3019465B1 (fr) | Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen | |
BR112015012311A2 (pt) | produto | |
MA41809B1 (fr) | Biotine pour le traitement de la sclérose latérale amyotrophique | |
MX2015013122A (es) | Composiciones hidrofílicas de hialuronato modificado, revestimientos y métodos. | |
FR3005408B1 (fr) | Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette lies aux modifications du tissu adipeux |